Pharma's Almanac TV
PA TV
Follow the Journey
Companies We've Met
AES Clean Technology
Altis Biosystems
Arranta Bio
Avara Pharmaceutical Services
Avid Bioservices
BioVectra
Centaur BPS
Dynamk Capital
ECRI
Evolve Biologics
Federal Equipment Company
Globyz
Inceptor Bio
IPS-Integrated Project Services
Olon
Pii
Polpharma Biologics
PPD
RoosterBio
SanaClis
Sanofi AIS
SGD Pharma
SPI Pharma
TriRx Pharmaceutical Services
Yourway
Dashboard
Your Name
Your Email
Manage Account
Sign Out
Sign In
Register
Topics
Products
ADC
API - Small Molecule
Biologics
Biopharmaceuticals
Biosimilars
Cell and Gene Therapy
DNA
Drug Product
Drug Substance
Equipment
Generics
Immunotherapy
Injectables
Monoclonal Antibody
Novel Therapeutics
Oral Solid Dosage
Orphan Drugs
Parenterals
Stem Cells
Vaccine
Services
Big Data
Bioprocessing
Clinical Trials
Continuous Manufacturing
Diagnostics
Drug Delivery
Drug Development
Drug Discovery
Facility
Formulation
Innovation
Oncology
Patient Adherence
Patient Centric
Preclinical
Process Development
Quality
Regulatory
Research
Serialization
Segment
Biomanufacturing
Biotechnology
CDMO
Consulting
CRO
Engineering
Equipment
Excipients
Healthcare
Intermediates
Logistics
Manufacturing
Packaging
Supply Chain
Business
Agreement
Appointment
Business
Capacity Expansion
Collaboration
Growth
Investment
Licensing
M&A
Market Expansion
Market Intelligence
Market Prediction
New Facility
Strategic Partnership
Magazine
Current Issue
Archive
Reports
2021 Gene Therapy Report
2021 Biologics Report
2021 Sterile Drug Products Report
2021 API Market Report
2020 OSD Market Report
Community
Company A to Z
Content Filter
More+
Staffing
Media Kit
By The Numbers
Leadership
71 Articles Available
1
3
Can't find what you're looking for? Try our
advanced search
.
Leadership
SPI Pharma Appoints Scott Thomson as CEO
PR-M10-20-08
Leadership
Kymanox Adds Top Experts in Human Factors to Enhance Combination Product Capabilities
PR-M10-20-05
Leadership
A CEO’s Perspective: Positioning a CDMO for Significant Growth
PAP-Q3-20-CL-008
Leadership
Seqens CDMO North America Appoints Jean-Noel David as Managing Director
PR-M09-20-21
Cognate Announces the Appointment of Two Independent Board Members
PR-M08-20-NI-36
Appointment
SK pharmteco Announces General Manager to SK biotek Ireland
PR-M08-20-NI-10
Leadership
Sygnature Discovery Boosts Senior Management Team With Appointment of Dr. Paul Overton
PR-M06-20-NI-034
Leadership
Spectrum Pharmaceuticals Appoints Lyndah K. Dreiling, M.D., MBA, as Senior Vice President, Clinical Development
PR-M06-20-NI-006
Leadership
Hovione Announces the Appointment of Jean-Luc Herbeaux as Chief Operating Officer
PR-M05-20-NI-006
Leadership
Mylan Board Appoints Robert J. Coury As Executive Chairman
PR-M04-20-NI-026
Leadership
Dr. Gustavo Mahler Now a General Partner at Dynamk Capital
PR-M04-20-NI-013
CDMO Leadership
A Vision for Achieving Worldwide Biopharmaceutical CDMO Leadership
PAP-Q1-20-CL-003
Mergers and Acquisitions
Business Leadership: A Requirement for Successful M&A Outcomes
PAP-Q1-20-CL-029
Brexit
Accelerated Innovation Is the Key to the UK’s Post-Brexit Life Sciences Leadership
PAP-Q1-20-CL-040
Leadership
Company Founder Ingmar Hoerr Succeeds Daniel Menichella as CEO of CureVac AG
PR-M03-20-NI-023
Leadership
NJII’S Biopharma Division Announces Its Advisory Committee
PR-M03-20-NI-016
Leadership
Michael J. Reilly Promoted to CEO of Integrity Bio
PR-M03-20-NI-007
Leadership
Altavant Sciences Appoints Respiratory Disease Medical Expert as Chief Medical Officer
PR-M03-20-NI-002
Leadership
Everest Medicines Appoints Kerry Blanchard, M.D., Ph.D., as Director and Chief Executive Officer
PR-M02-20-NI-026
Leadership
Boston Pharmaceuticals Appoints Dr. Craig T. Basson, M.D., Ph.D., as Chief Medical Officer
PR-M02-20-NI-004
Leadership
Sarepta Therapeutics Appoints Renowned Biotech Executive John C. Martin to its Board of Directors
PR-M01-20-NI-033
Leadership
GRAIL Appoints Gautam Kollu as Chief Commercial Officer
PR-M12-19-NI-027
Leadership
Science 37 Names David Coman Chief Executive Officer
PR-M12-19-NI-004
Leadership
Kronos Bio Appoints Biopharma Industry Veteran Jorge F. DiMartino, M.D., Ph.D., as Chief Medical Officer
PR-M11-19-NI-029
1
3
»
